| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.22 |
1e-05 |
| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.22 |
3e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.21 |
8e-05 |